BioAtla, Inc. (BCAB)
1.26
-0.06
(-4.55%)
USD |
OTCM |
Sep 08, 16:00
BioAtla Total Liabilities (Quarterly) : 45.74M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.74M |
| March 31, 2026 | 45.88M |
| December 31, 2025 | 51.18M |
| September 30, 2025 | 47.14M |
| June 30, 2025 | 43.87M |
| March 31, 2025 | 37.74M |
| December 31, 2024 | 38.16M |
| September 30, 2024 | 39.27M |
| June 30, 2024 | 37.27M |
| March 31, 2024 | 39.48M |
| December 31, 2023 | 48.99M |
| September 30, 2023 | 56.66M |
| June 30, 2023 | 55.12M |
| March 31, 2023 | 48.12M |
| Date | Value |
|---|---|
| December 31, 2022 | 45.40M |
| September 30, 2022 | 46.48M |
| June 30, 2022 | 48.54M |
| March 31, 2022 | 40.60M |
| December 31, 2021 | 43.60M |
| September 30, 2021 | 46.93M |
| June 30, 2021 | 38.68M |
| March 31, 2021 | 33.17M |
| December 31, 2020 | 34.96M |
| September 30, 2020 | 137.29M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 65.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.506M |
| Shareholders Equity (Quarterly) | -36.24M |
| Debt to Equity Ratio | -0.1618 |
| Current Ratio | 0.2026 |
| Net Debt Paydown Yield | -15.42% |